Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7566354 | 1.00 | HIF1A (0.48) | HIF1ACYP11B1CYP11B2PDCD1CD274 | |
| SCHEMBL8370701 | 0.89 | HIF1A (0.51) | HIF1APDCD1CD274 | |
| SCHEMBL8370696 | 0.89 | HIF1A (0.51) | HIF1APDCD1CD274 | |
| SCHEMBL8780118 | 0.89 | HIF1A (0.51) | HIF1APDCD1CD274 | |
| SCHEMBL8372363 | 0.87 | HIF1A (0.48) | HIF1ACYP11B1CYP11B2PDCD1CD274 | |
| SCHEMBL8372364 | 0.87 | HIF1A (0.48) | HIF1ACYP11B1CYP11B2PDCD1CD274 | |
| SCHEMBL8780047 | 0.87 | HIF1A (0.48) | HIF1ACYP11B1CYP11B2PDCD1CD274 | |
| SCHEMBL7885086 | 0.87 | HIF1A (0.46) | HIF1APDCD1CD274 | |
| SCHEMBL8368320 | 0.87 | HIF1A (0.48) | HIF1AMRGPRX4 | |
| SCHEMBL8368318 | 0.87 | HIF1A (0.48) | HIF1AMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020115865-A1 | 2-methoxyimino-2- (pyridinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring | CANADA EMILY J (US) | 2002-08-22 | — | — | US | disclosed |
| US-6432990-B1 | FUNGICIDES | DOW AGROSCIENCES LLC | 2002-08-13 | — | — | US | disclosed |
| US-6369083-B1 | 2-methoxyimino-2 (pyrinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring | DOW AGROSCIENCES LLC | 2002-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115865-A1 | 2-methoxyimino-2- (pyridinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring | AADAC, MIDEAS, CNPY2 | HIF1A 4745/4885CYP11B1 2970/4885CYP11B2 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.